Modeling Reciprocal Genomic Disorders in Neuronal Cells and Cerebral Organoids

神经元细胞和脑类器官中相互基因组疾病的建模

基本信息

  • 批准号:
    10377357
  • 负责人:
  • 金额:
    $ 11.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Abstract The proposed research and training program will prepare Dr. Xander Nuttle to become an independent investigator focused on human genetics and neurodevelopmental genomics. Dr. Nuttle obtained a Ph.D. in Genome Sciences, investigating genes specifically duplicated along the human lineage, and has dedicated his postdoctoral training to the development of innovative methods of genome engineering in relation to human reciprocal genomic disorders (RGDs). He now seeks to develop new expertise in functional genomics by leveraging emerging stem-cell, single-cell, organoid, and genome engineering technologies to characterize mutations linked to neurodevelopmental disorders. The training program consists of two phases: two years acquiring new skills primarily through mentored research, followed by three years establishing an independent laboratory. The research plan incorporates both experimental and computational approaches, modeling RGDs in neuronal cells and cerebral organoids to gain insights into mechanisms of pathogenesis. Dr. Michael Talkowski, Associate Professor of Neurology at the Center for Genomic Medicine (CGM) at Massachusetts General Hospital (MGH), will serve as the primary mentor. Dr. Kevin Eggan, Professor of Stem Cell and Regenerative Biology at Harvard University, will provide complementary expertise as a co-mentor. The mentor and co-mentor are world leaders in psychiatric genetics, functional genomics, and cellular disease modeling. To supplement their mentorship, a team of investigators at various career stages will provide Dr. Nuttle with targeted training and career development advice. The CGM at MGH, Harvard, and the Broad Institute form a highly collaborative environment ideally positioned to support Dr. Nuttle’s transition to independence. Here, he will have access to abundant resources and tools and a wealth of diverse scientific and clinical expertise. RGDs are among the most common genetic subtypes of autism spectrum disorder, schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and intellectual disability. All RGDs involve recurrent deletions and duplications of particular genomic segments, yet the molecular details of how these dosage changes confer disease are not well understood. To address this challenge, we will (1) examine transcriptional signatures and neurite dynamics in RGD neuronal cellular models; (2) generate and characterize RGD cerebral organoid models; and (3) integrate high-throughput genome engineering with cellular modeling to identify driver genes underlying RGD-associated neurite phenotypes. This research will immerse Dr. Nuttle in several cutting-edge fields, giving him the opportunity to learn functional genomics, single-cell analysis, and brain organoid modeling. With these skills in hand, he will be able to functionally characterize genetic variation affecting neurodevelopment and be well-positioned to launch a productive independent research program.
抽象的 拟议的研究和培训计划将使Xander Nuttle博士成为独立 研究人员专注于人类遗传学和神经发育基因组学。 Nuttle博士获得了博士学位在 基因组科学,调查了沿着人类谱系专门复制的基因,并致力于他 与人类有关的创新方法开发创新方法的博士后培训 相互基因组疾病(RGD)。他现在寻求通过功能基因组学方面的新专业知识 利用新兴的干细胞,单细胞,器官和基因组工程技术来表征 与神经发育障碍有关的突变。培训计划包括两个阶段:两年 主要通过指导的研究获得新技能,然后建立独立的三年 实验室。 研究计划既包含了实验和计算方法,又将RGD建模 神经元细胞和大脑器官,以洞悉发病机理。迈克尔博士 马萨诸塞州基因组医学中心(CGM)神经病学副教授Talkowski 综合医院(MGH)将担任主要导师。干细胞教授Kevin Eggan博士 哈佛大学的再生生物学将提供完整的专业知识。精神 和同事是精神遗传学,功能基因组学和细胞疾病建模的世界领导者。 为了补充他们的心态,在各个职业阶段的一个调查人员团队将为Nuttle博士提供 有针对性的培训和职业发展建议。 MGH,哈佛大学和Broad Institute的CGM成立A 高度协作的环境理想地是支持Nuttle博士向独立的过渡。在这里,他 将可以使用丰富的资源和工具以及大量的科学和临床专业知识。 RGD是自闭症谱系障碍的最常见遗传亚型之一,精神分裂症, 双相情感障碍,注意力缺陷/多动症和知地残疾。所有RGD都涉及经常性 特定基因组段的删除和重复,但是这些剂量如何的分子细节 变化会议疾病尚不清楚。为了应对这一挑战,我们将(1)检查转录 RGD神经元细胞模型中的特征和神经动力学; (2)生成和表征RGD 大脑器官模型; (3)与细胞建模的集成高通量基因组工程 鉴定与RGD相关的神经蛋白表型的基因。这项研究将使Nuttle博士沉浸在 几个尖端领域,使他有机会学习功能基因组学,单细胞分析和 脑器官建模。有了这些技能,他将能够在功能上表征遗传变异 影响神经发育,并有充分的位置,以启动一项富有成效的独立研究计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander Nuttle其他文献

Alexander Nuttle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander Nuttle', 18)}}的其他基金

Deconstructing Reciprocal Genomic Disorders by Integration of Genome Engineering and Cellular Modeling
通过基因组工程和细胞建模的整合解构相互的基因组疾病
  • 批准号:
    9470125
  • 财政年份:
    2017
  • 资助金额:
    $ 11.03万
  • 项目类别:

相似国自然基金

伴1q21扩增MM细胞IFI16过表达通过刺激TAM增殖及活化促进自身发生发展的机制研究
  • 批准号:
    82200221
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
伴1q21扩增MM细胞IFI16过表达通过刺激TAM增殖及活化促进自身发生发展的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
新抑癌基因表观调控高危多发性骨髓瘤1q21区基因表达的多组学和机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
新抑癌基因表观调控高危多发性骨髓瘤1q21区基因表达的多组学和机制研究
  • 批准号:
    82270207
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
RNA m6A阅读器IGF2BP3通过CKS1B mRNA促进伴有染色体1q21扩增的多发性骨髓瘤细胞增殖的机制研究
  • 批准号:
    82100215
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Uncovering novel mechanisms and potential therapeutic targets for IgA vasculitis through GWAS and systems-level analysis of regulatory networks.
通过 GWAS 和调节网络的系统级分析揭示 IgA 血管炎的新机制和潜在治疗靶点。
  • 批准号:
    10723651
  • 财政年份:
    2023
  • 资助金额:
    $ 11.03万
  • 项目类别:
The schizophrenia-associated 3q29 deletion: genetic architecture of behavioral phenotypes
精神分裂症相关的 3q29 缺失:行为表型的遗传结构
  • 批准号:
    10579244
  • 财政年份:
    2023
  • 资助金额:
    $ 11.03万
  • 项目类别:
Defining the landscape of structural alterations in African American Multiple Myeloma
定义非裔美国人多发性骨髓瘤的结构改变
  • 批准号:
    10510606
  • 财政年份:
    2022
  • 资助金额:
    $ 11.03万
  • 项目类别:
Defining the landscape of structural alterations in African American Multiple Myeloma
定义非裔美国人多发性骨髓瘤的结构改变
  • 批准号:
    10651845
  • 财政年份:
    2022
  • 资助金额:
    $ 11.03万
  • 项目类别:
The schizophrenia-associated 3q29 deletion: genetic architecture of behavioral phenotypes
精神分裂症相关的 3q29 缺失:行为表型的遗传结构
  • 批准号:
    10382014
  • 财政年份:
    2022
  • 资助金额:
    $ 11.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了